AnaptysBio, Inc. (ANAB)

57.19 +1.78 (+3.21%) USD  |  NASDAQ  |  Feb 25, 09:57
More

AnaptysBio Net Income (Quarterly)

Net Income (Quarterly) Chart

View Net Income (Quarterly) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade